New York, Oct. 17 -- Latest results from a UN-coordinated international trial on four COVID-19 therapeutic drugs, indicate that they have "little or no" positive impact on preventing deaths in patients infected with the new coronavirus.

The Solidarity Therapeutics Trial, overseen by the World Health Organization (WHO), shows that medications Remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon, repurposed to treat new coronavirus infections, "appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients", WHO said in a statement on Friday.

The study, which began in March and spans more than 30 countries, looked at the effects of these treatments on overall mortal...